Healthy Extracts (HYEX) Long-Term Investments (2025)

Healthy Extracts' (HYEX) quarterly Long-Term Investments came in at $23.5 million in Q3 2025.

Healthy Extracts (HYEX) Long-Term Investments (2025) Analysis & Trends

Healthy Extracts' Long-Term Investments history runs 1 years deep, the most recent figure standing at $23.5 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.32 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 702.35 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Healthy Extracts 14.70 Mn 14.56 Mn 957,429.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 23.54 Mn